Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.8 SEK | +10.64% | +18.46% | +0.75% |
Apr. 26 | Nordic Shares Closed Up Friday; Medicover Series B Climbed Highest | DJ |
Apr. 25 | Transcript : NCAB Group AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Sales 2024 * | 4.03B 369M | Sales 2025 * | 4.46B 408M | Capitalization | 13.8B 1.26B |
---|---|---|---|---|---|
Net income 2024 * | 386M 35.28M | Net income 2025 * | 460M 42.05M | EV / Sales 2024 * | 3.51 x |
Net Debt 2024 * | 362M 33.05M | Net Debt 2025 * | 107M 9.76M | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
35.8
x | P/E ratio 2025 * |
30
x | Employees | 585 |
Yield 2024 * |
1.48% | Yield 2025 * |
1.67% | Free-Float | 95.27% |
Latest transcript on NCAB Group AB
1 day | +10.64% | ||
1 week | +18.46% | ||
Current month | +5.20% | ||
1 month | +6.88% | ||
3 months | +8.53% | ||
6 months | +39.11% | ||
Current year | +0.75% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Kruk
CEO | Chief Executive Officer | 56 | 20-09-30 |
Anders Forsén
DFI | Director of Finance/CFO | 62 | 07-12-31 |
Jan Pedersen
CTO | Chief Tech/Sci/R&D Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Kruk
CEO | Chief Executive Officer | 56 | 20-09-30 |
Director/Board Member | 53 | 16-12-31 | |
Gunilla Rudebjer
BRD | Director/Board Member | 65 | 17-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 73.8 | +10.64% | 491,938 |
24-04-25 | 66.7 | +1.21% | 533,619 |
24-04-24 | 65.9 | +1.31% | 120,254 |
24-04-23 | 65.05 | +3.25% | 115,322 |
24-04-22 | 63 | +1.12% | 222,822 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.75% | 1.14B | |
-0.99% | 47.9B | |
-7.22% | 16.52B | |
+16.63% | 11.14B | |
+3.69% | 8.6B | |
+49.91% | 8.21B | |
+6.14% | 7.53B | |
-17.23% | 7.42B | |
-14.19% | 6.94B | |
-12.95% | 6.78B |
- Stock Market
- Equities
- NCAB Stock